Loading…

Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography

The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CF...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology and bioengineering 2000-06, Vol.68 (5), p.576-583
Main Authors: Diogo, M. M., Queiroz, J. A., Monteiro, G. A., Martins, S. A. M., Ferreira, G. N. M., Prazeres, D. M. F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873
container_end_page 583
container_issue 5
container_start_page 576
container_title Biotechnology and bioengineering
container_volume 68
creator Diogo, M. M.
Queiroz, J. A.
Monteiro, G. A.
Martins, S. A. M.
Ferreira, G. N. M.
Prazeres, D. M. F.
description The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that >70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (
doi_str_mv 10.1002/(SICI)1097-0290(20000605)68:5<576::AID-BIT13>3.0.CO;2-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71086625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17665226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</originalsourceid><addsrcrecordid>eNqFke9r1DAYx4so7jb9F6SvZHvRM0mbpD1F2TqdhemJnsx3D7k0vWb215JW7X9vus4hKFwghCTf5_OEfDzvDUZLjBB5cfwlS7MTjBIeIJKgY4LcYIiesHhFX1HOVqvT7Dw4yzY4fB0u0TJdvyQBfeAt7mseeoupJghpQg68Q2uv3ZbHjD32DjDiCScRXXjNp8HoQkvR67bx28IXvhxtr6Vf6K1prbZ-Vwlb69z_oWTfGr9wc6ca5felMqIb_cHqZueXY27army3rlQ3vbuSt0hZmrYWfbtz2XJ84j0qRGXV07v1yPv67u0mfR9cri-y9PQykFHMwyDnOMnzhKlIIKkIxSoOBSOFjBOakwIJyWKWSMEkyaclCmOJJFU8whIVjnDkPZ-5nWlvBmV7qLWVqqpEo9rBAsfI_QShe4MER1FMSLQ3iDljlBDmgldzULrvs0YV0BldCzMCRjDJBZjkwiQKJlHwRy6wGCg4uQBOLtzKhRAQpGsgML312d0Thm2t8r-4s00X-DYHfupKjf_03dv2f13nA4cOZrS2vfp1jxbmOzAecgpXHy_g7DM536APDh3-Bnzv0G4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17665226</pqid></control><display><type>article</type><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</creator><creatorcontrib>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</creatorcontrib><description>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that &gt;70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (&lt;6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley &amp; Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</description><identifier>ISSN: 0006-3592</identifier><identifier>EISSN: 1097-0290</identifier><identifier>DOI: 10.1002/(SICI)1097-0290(20000605)68:5&lt;576::AID-BIT13&gt;3.0.CO;2-5</identifier><identifier>PMID: 10797245</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Ammonium compounds ; Chromatography - methods ; Chromatography, High Pressure Liquid ; cystic fibrosis ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator - isolation &amp; purification ; DNA ; Endotoxins - analysis ; Escherichia coli - chemistry ; Escherichia coli - genetics ; gene therapy ; Genetic Therapy - methods ; Genetic Vectors - isolation &amp; purification ; Humans ; Hydrophobic chromatography ; hydrophobic interaction chromatography ; nucleic acids ; plasmid purification ; Plasmids - genetics ; Precipitation (chemical) ; Purification ; Quality Control ; RNA</subject><ispartof>Biotechnology and bioengineering, 2000-06, Vol.68 (5), p.576-583</ispartof><rights>Copyright © 2000 John Wiley &amp; Sons, Inc.</rights><rights>Copyright 2000 John Wiley &amp; Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10797245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diogo, M. M.</creatorcontrib><creatorcontrib>Queiroz, J. A.</creatorcontrib><creatorcontrib>Monteiro, G. A.</creatorcontrib><creatorcontrib>Martins, S. A. M.</creatorcontrib><creatorcontrib>Ferreira, G. N. M.</creatorcontrib><creatorcontrib>Prazeres, D. M. F.</creatorcontrib><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><title>Biotechnology and bioengineering</title><addtitle>Biotechnol. Bioeng</addtitle><description>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that &gt;70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (&lt;6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley &amp; Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</description><subject>Ammonium compounds</subject><subject>Chromatography - methods</subject><subject>Chromatography, High Pressure Liquid</subject><subject>cystic fibrosis</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - isolation &amp; purification</subject><subject>DNA</subject><subject>Endotoxins - analysis</subject><subject>Escherichia coli - chemistry</subject><subject>Escherichia coli - genetics</subject><subject>gene therapy</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors - isolation &amp; purification</subject><subject>Humans</subject><subject>Hydrophobic chromatography</subject><subject>hydrophobic interaction chromatography</subject><subject>nucleic acids</subject><subject>plasmid purification</subject><subject>Plasmids - genetics</subject><subject>Precipitation (chemical)</subject><subject>Purification</subject><subject>Quality Control</subject><subject>RNA</subject><issn>0006-3592</issn><issn>1097-0290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFke9r1DAYx4so7jb9F6SvZHvRM0mbpD1F2TqdhemJnsx3D7k0vWb215JW7X9vus4hKFwghCTf5_OEfDzvDUZLjBB5cfwlS7MTjBIeIJKgY4LcYIiesHhFX1HOVqvT7Dw4yzY4fB0u0TJdvyQBfeAt7mseeoupJghpQg68Q2uv3ZbHjD32DjDiCScRXXjNp8HoQkvR67bx28IXvhxtr6Vf6K1prbZ-Vwlb69z_oWTfGr9wc6ca5felMqIb_cHqZueXY27army3rlQ3vbuSt0hZmrYWfbtz2XJ84j0qRGXV07v1yPv67u0mfR9cri-y9PQykFHMwyDnOMnzhKlIIKkIxSoOBSOFjBOakwIJyWKWSMEkyaclCmOJJFU8whIVjnDkPZ-5nWlvBmV7qLWVqqpEo9rBAsfI_QShe4MER1FMSLQ3iDljlBDmgldzULrvs0YV0BldCzMCRjDJBZjkwiQKJlHwRy6wGCg4uQBOLtzKhRAQpGsgML312d0Thm2t8r-4s00X-DYHfupKjf_03dv2f13nA4cOZrS2vfp1jxbmOzAecgpXHy_g7DM536APDh3-Bnzv0G4</recordid><startdate>20000605</startdate><enddate>20000605</enddate><creator>Diogo, M. M.</creator><creator>Queiroz, J. A.</creator><creator>Monteiro, G. A.</creator><creator>Martins, S. A. M.</creator><creator>Ferreira, G. N. M.</creator><creator>Prazeres, D. M. F.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20000605</creationdate><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><author>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Ammonium compounds</topic><topic>Chromatography - methods</topic><topic>Chromatography, High Pressure Liquid</topic><topic>cystic fibrosis</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - isolation &amp; purification</topic><topic>DNA</topic><topic>Endotoxins - analysis</topic><topic>Escherichia coli - chemistry</topic><topic>Escherichia coli - genetics</topic><topic>gene therapy</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors - isolation &amp; purification</topic><topic>Humans</topic><topic>Hydrophobic chromatography</topic><topic>hydrophobic interaction chromatography</topic><topic>nucleic acids</topic><topic>plasmid purification</topic><topic>Plasmids - genetics</topic><topic>Precipitation (chemical)</topic><topic>Purification</topic><topic>Quality Control</topic><topic>RNA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diogo, M. M.</creatorcontrib><creatorcontrib>Queiroz, J. A.</creatorcontrib><creatorcontrib>Monteiro, G. A.</creatorcontrib><creatorcontrib>Martins, S. A. M.</creatorcontrib><creatorcontrib>Ferreira, G. N. M.</creatorcontrib><creatorcontrib>Prazeres, D. M. F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diogo, M. M.</au><au>Queiroz, J. A.</au><au>Monteiro, G. A.</au><au>Martins, S. A. M.</au><au>Ferreira, G. N. M.</au><au>Prazeres, D. M. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</atitle><jtitle>Biotechnology and bioengineering</jtitle><addtitle>Biotechnol. Bioeng</addtitle><date>2000-06-05</date><risdate>2000</risdate><volume>68</volume><issue>5</issue><spage>576</spage><epage>583</epage><pages>576-583</pages><issn>0006-3592</issn><eissn>1097-0290</eissn><abstract>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that &gt;70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (&lt;6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley &amp; Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10797245</pmid><doi>10.1002/(SICI)1097-0290(20000605)68:5&lt;576::AID-BIT13&gt;3.0.CO;2-5</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3592
ispartof Biotechnology and bioengineering, 2000-06, Vol.68 (5), p.576-583
issn 0006-3592
1097-0290
language eng
recordid cdi_proquest_miscellaneous_71086625
source Wiley-Blackwell Read & Publish Collection
subjects Ammonium compounds
Chromatography - methods
Chromatography, High Pressure Liquid
cystic fibrosis
Cystic Fibrosis Transmembrane Conductance Regulator - genetics
Cystic Fibrosis Transmembrane Conductance Regulator - isolation & purification
DNA
Endotoxins - analysis
Escherichia coli - chemistry
Escherichia coli - genetics
gene therapy
Genetic Therapy - methods
Genetic Vectors - isolation & purification
Humans
Hydrophobic chromatography
hydrophobic interaction chromatography
nucleic acids
plasmid purification
Plasmids - genetics
Precipitation (chemical)
Purification
Quality Control
RNA
title Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A02%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification%20of%20a%20cystic%20fibrosis%20plasmid%20vector%20for%20gene%20therapy%20using%20hydrophobic%20interaction%20chromatography&rft.jtitle=Biotechnology%20and%20bioengineering&rft.au=Diogo,%20M.%20M.&rft.date=2000-06-05&rft.volume=68&rft.issue=5&rft.spage=576&rft.epage=583&rft.pages=576-583&rft.issn=0006-3592&rft.eissn=1097-0290&rft_id=info:doi/10.1002/(SICI)1097-0290(20000605)68:5%3C576::AID-BIT13%3E3.0.CO;2-5&rft_dat=%3Cproquest_cross%3E17665226%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17665226&rft_id=info:pmid/10797245&rfr_iscdi=true